Fast and simple purification of chemically modified hammerhead ribozymes using a lipophilic capture tag

被引:22
作者
Sproat, BS [1 ]
Rupp, T [1 ]
Menhardt, N [1 ]
Keane, D [1 ]
Beijer, B [1 ]
机构
[1] Innovir GmbH, D-37124 Rosdorf, Germany
关键词
D O I
10.1093/nar/27.8.1950
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new type of S-lipophilic capture tag is described, enabling the facile reverse phase HPLC purification of chemically modified hammerhead ribozymes (oligozymes) whilst still carrying the 2'-O-tert.-butyldimethylsilyl protection of the essential riboses, In its most convenient form, the capture tag consists of a simple diol, such as hexan-1,6-diol, which at one end is attached via a silyl residue to a highly lipophilic entity such as tocopherol (vitamin E) or cholesterol, and the other end is functionalized as a phosphoramidite, This lipophilic capture tag is added as the last residue in the solid-phase synthesis of chemically modified hammerhead ribozymes, Cleavage from the support and release of all protecting groups except for the silyl groups is achieved with ethanolamine/ethanol. The crude product is then loaded directly on to a reverse phase HPLC column. Separation of failure peaks from full length product is achieved easily using a short run time. The retarded product peak is collected, lyophilized, desilylated in the normal way and then desalted, This method removes the lipophilic capture tag yet leaves behind the hexanediol entity which helps protect the compound against degradation by 5'-exonucleases. The purity of the product as judged by analytical anion-exchange HPLC and capillary gel electrophoresis is generally better than 95% full-length, and yields of 2-4 mg from a 1 mu mol scale synthesis are routine. In addition, the method can be readily scaled up, an important feature for the development of such chemically modified ribozymes as potential therapeutics.
引用
收藏
页码:1950 / 1955
页数:6
相关论文
共 23 条
[1]   The structure, function and application of the hammerhead ribozyme [J].
Birikh, KR ;
Heaton, PA ;
Eckstein, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (01) :1-16
[2]   RIBOZYMES AS HUMAN THERAPEUTIC AGENTS [J].
CHRISTOFFERSEN, RE ;
MARR, JJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) :2023-2037
[3]   Preparative-scale purification of RNA using an efficient method which combines gel electrophoresis and column chromatography [J].
Cunningham, L ;
Kittikamron, K ;
Lu, Y .
NUCLEIC ACIDS RESEARCH, 1996, 24 (18) :3647-3648
[4]   SYNTHESIS OF RNA CONTAINING INOSINE - ANALYSIS OF THE SEQUENCE REQUIREMENTS FOR THE 5' SPLICE SITE OF THE TETRAHYMENA GROUP-I INTRON [J].
GREEN, R ;
SZOSTAK, JW ;
BENNER, SA ;
RICH, A ;
USMAN, N .
NUCLEIC ACIDS RESEARCH, 1991, 19 (15) :4161-4166
[5]   SIMPLE RNA ENZYMES WITH NEW AND HIGHLY SPECIFIC ENDORIBONUCLEASE ACTIVITIES [J].
HASELOFF, J ;
GERLACH, WL .
NATURE, 1988, 334 (6183) :585-591
[6]   NUMBERING SYSTEM FOR THE HAMMERHEAD [J].
HERTEL, KJ ;
PARDI, A ;
UHLENBECK, OC ;
KOIZUMI, M ;
OHTSUKA, E ;
UESUGI, S ;
CEDERGREN, R ;
ECKSTEIN, F ;
GERLACH, WL ;
HODGSON, R ;
SYMONS, RH .
NUCLEIC ACIDS RESEARCH, 1992, 20 (12) :3252-3252
[7]   Extending the cleavage rules for the hammerhead ribozyme:: mutating adenosine15.1 to inosine15.1 changes the cleavage site specificity from N16.2U16.1H17 to N16.2C16.1H17 [J].
Ludwig, J ;
Blaschke, M ;
Sproat, BS .
NUCLEIC ACIDS RESEARCH, 1998, 26 (10) :2279-2285
[8]   Purification of 5'-O-trityl-on oligoribonucleotides. Investigation of phosphate migration during purification and detritylation. [J].
Mullah, B ;
Andrus, A .
NUCLEOSIDES & NUCLEOTIDES, 1996, 15 (1-3) :419-430
[9]  
Ortigao J F, 1992, Antisense Res Dev, V2, P129
[10]   LARGE-SCALE SYNTHESIS, PURIFICATION, AND ANALYSIS OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES [J].
PADMAPRIYA, AA ;
TANG, JY ;
AGRAWAL, S .
ANTISENSE RESEARCH AND DEVELOPMENT, 1994, 4 (03) :185-199